🟢 ⬇️ incidence pleural meso over time
🔺 no ⬇️ in sarcomatoid / biphasic
🟢 ⬆️ 2yr survival over time
👉 Older pts less likely to get SACT
👉 ⬇️ RT use over time
Publicly available 👏
nhsd-ndrs.shinyapps.io/get_data_out/
👉 T-cell engagers
👉 CAR-T
👉 Vaccines
👉 Intra-pleural vaccines
All interesting, but increasingly complex with significant toxicities. No efficacy data yet.
‘Low hanging fruit’ of immunotherapy already taken
Radiotherapy for mesothelioma
👍 Meso is radiosensitive
❌ Prophylactic tract RT
🟢 Palliative thoracic RT: ⬇️ symptoms, might ⬆️ OS (SYSTEMS-2)
❓Palliative hemithoracic RT: ⬆️ OS, but toxicity++
⚡️ Protons: x2 🇬🇧 centres
👏 HIT-Meso trial ongoing at UCL + Manchester
& markers of quality care at end-of-life today at #MesoUpdate24
Our study will be published in @palliativemedj.bsky.social any day now!
@btog.bsky.social
& markers of quality care at end-of-life today at #MesoUpdate24
Our study will be published in @palliativemedj.bsky.social any day now!
@btog.bsky.social
@donnawakefield.bsky.social #mesoupdate24 #LCSM #lungcancer #mesothelioma
@donnawakefield.bsky.social #mesoupdate24 #LCSM #lungcancer #mesothelioma
#mesoupdate24 day yesterday. #LCSM #lungcancer #mesothelioma #BTOG
#mesoupdate24 day yesterday. #LCSM #lungcancer #mesothelioma #BTOG
#mesoupdate24 #LCSM #lungcancer #mesothelioma
#mesoupdate24 #LCSM #lungcancer #mesothelioma
#mesoupdate24 #LCSM #lungcancer #mesothelioma
#mesoupdate24 #LCSM #lungcancer #mesothelioma
#mesoupdate24 #LCSM #lungcancer #mesothelioma
#mesoupdate24 #LCSM #lungcancer #mesothelioma
#mesoupdate24 #LCSM #lungcancer #mesothelioma
#mesoupdate24 #LCSM #lungcancer #mesothelioma
👉 (small) subset of non-epithelioid pts do very well with Vin
🟢 Gem+Ramucirumab = ⬆️ PFS
❓ Gem maintenance = ⬆️ PFS, but a bit forgotten
🟢 Platinum rechallenge RR 50%
❓Activity in immuno rechallenge, RR up to 50%
🧐 How does inflammation evolve into malignancy?
🧐 Can we diagnose mesothelioma at pre-malignant stage?
👉 80 institutions, 16 countries
👉 x5 work streams
Fantastic, ambitious, international, multi-faceted project
@btog.bsky.social
@mesouk.bsky.social
Andrea Bille reminds us of MARS2 data:
Surgery =
⬇️ OS
⬆️ SAEs
⬇️ QoL (<6m)
⬆️ Cost (£30.4K v 15.8K)
Useful additional data from Italian surgical studies
Andrea Bille reminds us of MARS2 data:
Surgery =
⬇️ OS
⬆️ SAEs
⬇️ QoL (<6m)
⬆️ Cost (£30.4K v 15.8K)
Useful additional data from Italian surgical studies
#mesoupdate24 #LCSM #lungcancer #mesothelioma
#mesoupdate24 #LCSM #lungcancer #mesothelioma
👉 Too many non-epithelioid, older pts
👉 Too much: diaphragm resection in 80%
👉 Too late: insufficient pre-op staging
= ⬆️ complications & deaths
Post-hoc analysis: 70% pts would not now be surgical candidates
Brilliant to see such enthusiasm for #Mesothelioma from all backgrounds- respiratory/oncology/surgery/pathology/palliative care/legal, clinical and non-clinical researchers all working together 🙌
Brilliant to see such enthusiasm for #Mesothelioma from all backgrounds- respiratory/oncology/surgery/pathology/palliative care/legal, clinical and non-clinical researchers all working together 🙌
Nick Maskell. Our first speaker in this final session for the day is Sarah Johnstone, telling us about the role of a pleural nurse.
#mesoupdate24 #LCSM #lungcancer #mesothelioma
Nick Maskell. Our first speaker in this final session for the day is Sarah Johnstone, telling us about the role of a pleural nurse.
#mesoupdate24 #LCSM #lungcancer #mesothelioma
The first speaker, Riyaz Shah of the Kent Oncology Centre talks about 1st line Systemic Anti-Cancer Therapy (SACT)
#mesoupdate24 #LCSM #lungcancer #mesothelioma
The first speaker, Riyaz Shah of the Kent Oncology Centre talks about 1st line Systemic Anti-Cancer Therapy (SACT)
#mesoupdate24 #LCSM #lungcancer #mesothelioma